![Carole Ho](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carole Ho
Direttore/Membro del Consiglio presso
ROYALTY PHARMA PLC
Patrimonio netto: 12 M $ in data 30/06/2026
Profilo
La dottoressa Carole Ho, MD, è un amministratore indipendente di NGM Biopharmaceuticals, Inc., un amministratore indipendente di Beam Therapeutics, Inc. e un Chief Medical Officer & Head-Development di Denali Therapeutics, Inc. Fa parte del Consiglio di amministrazione di NGM Biopharmaceuticals, Inc. e Beam Therapeutics, Inc. La dottoressa Ho è stata precedentemente impiegata come VP-Non Oncology Early Clinical Development presso Genentech, Inc. e come direttore medico presso Johnson & Johnson. Si è laureata all'Harvard College e ha conseguito il dottorato al Weill Cornell Medical College.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 13/08/2025 | 424.804 ( 0,27% ) | 11 M $ | 30/06/2026 | |
| 05/06/2026 | 13.103 ( 0% ) | 734 685 $ | 30/06/2026 | |
| 04/06/2025 | 0 ( -.--% ) | - $ | 30/06/2026 |
Posizioni attive di Carole Ho
| Società | Posizione | Inizio |
|---|---|---|
| ROYALTY PHARMA PLC | Direttore/Membro del Consiglio | 17/07/2025 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 06/11/2025 |
Precedenti posizioni note di Carole Ho
| Società | Posizione | Fine |
|---|---|---|
| BEAM THERAPEUTICS INC. | Direttore/Membro del Consiglio | 27/02/2026 |
| DENALI THERAPEUTICS INC. | Direttore Tecnico/Scientifico/R&S | 06/11/2025 |
| NGM BIOPHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 05/04/2024 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/06/2015 |
| JOHNSON & JOHNSON | Direttore Tecnico/Scientifico/R&S | 01/10/2007 |
Formazione di Carole Ho
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
68
Relazioni di 1° grado
10
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
NGM Biopharmaceuticals, Inc.
 NGM Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel & life-changing medicines | Health Technology |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Health Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Denali Therapeutics, Inc.
 Denali Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurodegenerative diseases | Health Technology |
Beam Therapeutics, Inc.
 Beam Therapeutics, Inc. BiotechnologyHealth Technology Operate as a biotechnology company that develops precision genetic medicines, gene editing and delivery technologies | Health Technology |
Weill Cornell Medicine
 Weill Cornell Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Royalty Pharma Plc
 Royalty Pharma Plc Pharmaceuticals: MajorHealth Technology Buys and operates a portfolio of biopharmaceutical royalties | Health Technology |
